1 September 2026
by Dr. Pranab Gyawali | 21 days ago
We are starting to use more blood tests and biomarkers to help make biologic treatment decisions in IBD more precise. In this video, I discuss a patient with active ulcerative colitis who is starting infliximab and how tests such as HLA DQA1 05 and HLA DRB1 01:03 can add useful information when discussing treatment.
